1-3 of 3
Katerina Pavenski
Close
Sort by
Journal Articles

Blood–brain barrier permeability in survivors of immune-mediated thrombotic thrombocytopenic purpura: a pilot study

Clinical Trials & Observations
Shih-Han Susan Huang, Katerina Pavenski, Ting-Yim Lee, Michael T. Jurkiewicz, Aditya Bharatha, Jonathan Dale Thiessen, Keith St. Lawrence, Jean Théberge, Jennifer Mandzia, David Barth, Christoph Licht, Christopher Jordan Patriquin
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4211–4218.
https://doi.org/10.1182/bloodadvances.2021005317
Published: 2021
Includes: Supplemental data
Journal Articles

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis

Clinical Trials & Observations
Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Jessica Minkue Mi Edou, Hilde De Winter, Filip Callewaert
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2137–2141.
https://doi.org/10.1182/bloodadvances.2020001834
Published: 2021
Includes: Supplemental data
Journal Articles

Bendamustine-induced immune hemolytic anemia: a case report and systematic review of the literature

Clinical Trials & Observations
Maverick Chan, William K. Silverstein, Anna Nikonova, Katerina Pavenski, Lisa K. Hicks
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1756–1759.
https://doi.org/10.1182/bloodadvances.2020001726
Published: 2020